ArticleScientific reports2025
Toxicological insights into the non-target effects of ornidazole using the Allium cepa bioassay system.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, the biochemical and cytogenetic toxicity induced by the antibiotic active ingredient ornidazole in the non-target organism Allium cepa L. was investigated. In the toxicity assessment, the level of malondialdehyde (MDA), a biochemical marker of lipid peroxidation; genotoxicity indicators such as micronucleus (MN) frequency and mitotic index (MI); the incidence of chromosomal abnormalities (CAs); activities of antioxidant defense enzymes catalase (CAT) and superoxide dismutase (SOD); and the levels of chlorophyll a and b pigments reflecting photosynthetic capacity were analyzed. Additionally, DNA damage was assessed using the Comet test method, and the interaction of ornidazole with macromolecules-particularly DNA-was examined using the molecular docking approach. Four groups of A. cepa bulbs-one control and three treatments-were created. Three distinct dosages (0.0179, 0.0357 and 0.0714 mg/L) of ornidazole were used to germinate the bulbs in the treatment group, while tap water was used to germinate the bulbs in the control group. Following germination, samples from the roots and leaves were gathered and ready for examination. As a result, there was no cytogenetic damage or biochemical alteration that was statistically significant (p > 0.05) in the control group (Group I). MI value, DNA, and chlorophyll levels significantly (p < 0.05) decreased with ornidazole treatment, while MN frequency, CAs, MDA levels, SOD, and CAT activities significantly (p < 0.05) increased. At the ornidazole dosage of 0.0714 mg/L, these rises and declines were shown to be more noticeable. Ornidazole promoted several CAs in root meristem cells, the most common being the sticky chromosome. DNA damage was highlighted by the comet assay results, which indicated a drop in head DNA and an increase in tail DNA. In the control group, the Tail DNA was 1.00 ± 1.05 (%), whereas in the group treated with 0.0714 mg/L ornidazole, it increased to 72.0 ± 1.63 (5), indicating high DNA fragmentation. Molecular docking results showed ornidazole-DNA, ornidazole-tubulin, ornidazole-topoisomerase, ornidazole-glutamate-1-semialdehyde aminotransferase and ornidazole-protochlorophyllide reductase interaction supporting the biochemical and cytogenetic toxicity results. In conclusion, ornidazole exposure induced significant toxic effects in the non-target organism Allium cepa. The study further validated the efficacy of the Allium test as a reliable bioassay for detecting such toxicity. These findings underscore the urgent need for implementing appropriate environmental management strategies to mitigate pharmaceutical contamination and protect non-target organisms from drug-induced toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.